Jasper Therapeutics, Inc. releases its Q3 2026 results, showcasing developments in biological products and potential impacts on the biotech industry.
| Name | Jasper Therapeutics, Inc. |
|---|---|
| CIK | 0001788028 |
| Tickers | JSPR |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 842984849 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 6505491400 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Jasper Therapeutics, Inc. releases its Q3 2026 results, showcasing developments in biological products and potential impacts on the biotech industry.
Jasper Therapeutics announces Q3 2026 results, showcasing progress in clinical trials and corporate updates, signaling growth in the biological products sector.
Affinity Asset Advisors, LLC and Michael Cho report a 5.6% stake in Jasper Therapeutics, reflecting increased investment interest in the biological products sector.
Jasper Therapeutics has completed its warrant buyback, acquiring 68.94% of outstanding warrants, enhancing its financial position in the biotechnology sector.
Jasper Therapeutics has filed for a 1-for-30 reverse stock split, effective November 6, 2026, aiming to enhance stock price and attract investors.
Bank of America Corp has acquired a 6.4% stake in Jasper Therapeutics, indicating increased interest in the biological products sector.
Jasper Therapeutics has amended its tender offer statement, indicating a strategic shift in its acquisition plans that may influence the biological products industry.
Jasper Therapeutics has filed a definitive proxy statement, detailing proposals for its upcoming shareholder meeting, impacting corporate governance in the biotech sector.
Jasper Therapeutics announces completion of enrollment in its Phase 2 study of vensobafusp alfa for IgA nephropathy, with initial data expected by year-end 2026.
Jasper Therapeutics announces an offer to buy back outstanding warrants to reduce dilution and enhance investor confidence in its capital structure.
Jasper Therapeutics' stockholders approved major proposals at a recent meeting, impacting the company's stock structure and future operations.
489 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005239 | 005-91228 | 261558028 | 34 | 10485 | |||
| 2026-11-16 | 10-Q | QUARTERLY REPORT | 0001213900-26-120161 | 001-39138 | 261555572 | 34 | 9325261 | 1 | 1 | |
| 2026-11-16 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-26-120141 | 001-39138 | 261555534 | 34 | 305957 | 1 | 1 |
| 2026-11-13 | 8-K | CURRENT REPORT | 8.01 | 0001213900-26-119785 | 001-39138 | 261553179 | 34 | 188999 | 1 | 1 |
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000690 | 005-91228 | 261552485 | 34 | 17328 | |||
| 2026-11-09 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-117230 | 001-39138 | 261533910 | 34 | 233791 | 1 | 1 |
| 2026-11-04 | 8-K | CURRENT REPORT | 3.03,5.03,7.01,9.01 | 0001213900-26-115751 | 001-39138 | 261520135 | 34 | 263561 | 1 | 1 |
| 2026-10-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000538 | 005-91228 | 261495054 | 34 | 171418 | |||
| 2026-10-23 | SC TO-I/A | AMENDMENT NO. 1 TO FORM SC TO-I | 0001213900-26-112090 | 005-91228 | 261482141 | 34 | 205040 | |||
| 2026-10-19 | DEF 14A | PROXY STATEMENT | 0001213900-26-110751 | 001-39138 | 261470706 | 34 | 5334128 | |||
| 2026-10-15 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-109587 | 001-39138 | 261461365 | 34 | 244366 | 1 | 1 |
| 2026-10-14 | S-3 | REGISTRATION STATEMENT | 0001213900-26-109479 | 333-299459 | 261460609 | 33 | 504079 | 1 | 1 | |
| 2026-10-09 | PRE 14A | PROXY STATEMENT | 0001213900-26-108482 | 001-39138 | 261453491 | 34 | 5334982 | |||
| 2026-10-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-107402 | 001-39138 | 261445496 | 34 | 238327 | 1 | 1 |
| 2026-10-07 | SC TO-I | FORM SC TO-I | 0001213900-26-107397 | 005-91228 | 261445469 | 34 | 1038535 | 1 | 1 | |
| 2026-10-05 | 8-K | CURRENT REPORT | 5.07 | 0001213900-26-106651 | 001-39138 | 261438812 | 34 | 201643 | 1 | 1 |
| 2026-10-05 | 8-K/A | AMENDMENT NO. 2 TO FORM 8-K | 9.01 | 0001213900-26-106574 | 001-39138 | 261438355 | 34 | 401875 | 1 | 1 |
| 2026-10-01 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 9.01 | 0001213900-26-105924 | 001-39138 | 261432630 | 34 | 930866 | 1 | 1 |
| 2026-09-28 | 8-K | CURRENT REPORT | 5.02 | 0001213900-26-104101 | 001-39138 | 261417933 | 34 | 188913 | 1 | 1 |
| 2026-09-24 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-26-000914 | 001-39138 | 261404943 | 34 | 3214 | |||
| 2026-09-04 | DEF 14A | PROXY STATEMENT | 0001213900-26-097572 | 001-39138 | 261361828 | 34 | 3769678 | |||
| 2026-08-26 | 8-K | CURRENT REPORT | 1.01 | 0001213900-26-093979 | 001-39138 | 261323134 | 34 | 245206 | 1 | 1 |
| 2026-08-24 | PRE 14A | PROXY STATEMENT | 0001213900-26-093145 | 001-39138 | 261311752 | 34 | 3770193 | |||
| 2026-08-17 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002220 | 005-91228 | 261286741 | 34 | 46110 | |||
| 2026-08-14 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-26-090055 | 001-39138 | 261281432 | 34 | 336896 | 1 | 1 |
| 2026-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-089592 | 001-39138 | 261277823 | 34 | 7070782 | 1 | 1 | |
| 2026-08-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001213900-26-085315 | 021-593140 | 261240655 | 33 | 12792 | ||
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001213900-26-085192 | 6009 | ||||||
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001213900-26-085191 | 5996 | ||||||
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001213900-26-085190 | 21945 | ||||||
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001213900-26-085189 | 6000 | ||||||
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001213900-26-085188 | 6036 | ||||||
| 2026-08-03 | 8-K | CURRENT REPORT | 5.07 | 0001213900-26-084687 | 001-39138 | 261233857 | 34 | 247995 | 1 | 1 |
| 2026-07-31 | 8-K | CURRENT REPORT | 8.01 | 0001213900-26-083563 | 001-39138 | 261225257 | 34 | 244383 | 1 | 1 |
| 2026-07-23 | 3 | xslF345X06/ownership.xml | 0001213900-26-080864 | 20469 | ||||||
| 2026-07-22 | 4 | xslF345X06/ownership.xml | 0001213900-26-080525 | 6995 | ||||||
| 2026-07-22 | 3 | xslF345X06/ownership.xml | 0001213900-26-080524 | 28288 | ||||||
| 2026-07-22 | 3 | xslF345X06/ownership.xml | 0001213900-26-080523 | 21046 | ||||||
| 2026-07-20 | 4 | xslF345X06/ownership.xml | 0001213900-26-079764 | 9363 | ||||||
| 2026-07-20 | 3 | xslF345X06/ownership.xml | 0001213900-26-079762 | 5745 | ||||||
| 2026-07-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000921895-26-001834 | 005-91228 | 261187380 | 34 | 26915 | |||
| 2026-07-17 | 8-K | CURRENT REPORT | 1.01,2.01,3.02,5.02,5.03,7.01,9.01 | 0001213900-26-078887 | 001-39138 | 261181741 | 34 | 17913469 | 1 | 1 |
| 2026-07-16 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-26-078781 | 001-39138 | 261181192 | 34 | 290172 | 1 | 1 |
| 2026-07-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-082738 | 005-91228 | 261169675 | 34 | 19543 | |||
| 2026-06-15 | ARS | ARS | 0001213900-26-068772 | 001-39138 | 261090762 | 34 | 976180 | |||
| 2026-06-15 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-068767 | 001-39138 | 261090728 | 34 | 3682255 | |||
| 2026-06-15 | DEF 14A | PROXY STATEMENT | 0001213900-26-068765 | 001-39138 | 261090713 | 34 | 10043016 | 1 | 1 | |
| 2026-06-09 | 8-K | CURRENT REPORT | 3.01 | 0001213900-26-066782 | 001-39138 | 261076084 | 34 | 247400 | 1 | 1 |
| 2026-06-01 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-26-063157 | 001-39138 | 261047271 | 34 | 287131 | 1 | 1 |
| 2026-05-21 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-26-060029 | 001-39138 | 261008244 | 34 | 237220 | 1 | 1 |
| 2026-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-056595 | 001-39138 | 26978754 | 34 | 5019343 | 1 | 1 | |
| 2026-05-14 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-26-056596 | 001-39138 | 26978714 | 34 | 326954 | 1 | 1 |
| 2026-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000895421-26-000171 | 005-91228 | 26967264 | 34 | 12411 | |||
| 2026-05-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-053990 | 005-91228 | 26959501 | 34 | 29584 | |||
| 2026-05-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000153 | 005-91228 | 26957505 | 34 | 18480 | |||
| 2026-04-30 | 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-050178 | 001-39138 | 26924824 | 34 | 783403 | 1 | 1 | |
| 2026-03-30 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-26-036448 | 001-39138 | 26813485 | 34 | 334489 | 1 | 1 |
| 2026-03-30 | 10-K | ANNUAL REPORT | 0001213900-26-036426 | 001-39138 | 26813402 | 34 | 9676785 | 1 | 1 | |
| 2026-02-25 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-019751 | 005-91228 | 26679662 | 34 | 18867 | |||
| 2026-02-18 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-26-007366 | 005-91228 | 26650356 | 34 | 20160 | |||
| 2026-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000886982-26-000077 | 005-91228 | 26624094 | 34 | 18222 | |||
| 2026-02-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-26-000039 | 005-91228 | 26619800 | 34 | 11948 | |||
| 2026-02-10 | 4 | xslF345X05/ownership.xml | 0001213900-26-014244 | 5752 | ||||||
| 2026-01-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-26-000002 | 005-91228 | 26560330 | 34 | 12653 | |||
| 2026-01-08 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-002329 | 001-39138 | 26517341 | 34 | 36164504 | 1 | 1 |
| 2026-01-07 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-26-002185 | 001-39138 | 26516112 | 34 | 289927 | 1 | 1 |
| 2026-01-05 | 4 | xslF345X05/ownership.xml | 0001213900-26-001385 | 5745 | ||||||
| 2026-01-05 | 4 | xslF345X05/ownership.xml | 0001213900-26-001383 | 5737 | ||||||
| 2026-01-05 | 4 | xslF345X05/ownership.xml | 0001213900-26-001382 | 5652 | ||||||
| 2025-12-02 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-25-000064 | 005-91228 | 251541911 | 34 | 12515 | |||
| 2025-12-02 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-116943 | 001-39138 | 251541561 | 34 | 14980407 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001765710-25-000005 | 005-91228 | 251488298 | 34 | 13188 | |||
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000546 | 005-91228 | 251483354 | 34 | 7555 | |||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-006584 | 005-91228 | 251471268 | 34 | 14631 | |||
| 2025-11-10 | 10-Q | QUARTERLY REPORT | 0001213900-25-107884 | 001-39138 | 251464498 | 34 | 5995978 | 1 | 1 | |
| 2025-11-10 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-25-107874 | 001-39138 | 251464449 | 34 | 357164 | 1 | 1 |
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000572 | 005-91228 | 251461600 | 34 | 8177 | |||
| 2025-09-24 | 4 | xslF345X05/ownership.xml | 0001213900-25-091105 | 8080 | ||||||
| 2025-09-24 | 4 | xslF345X05/ownership.xml | 0001213900-25-091104 | 7229 | ||||||
| 2025-09-24 | 4 | xslF345X05/ownership.xml | 0001213900-25-091099 | 7270 | ||||||
| 2025-09-24 | 4 | xslF345X05/ownership.xml | 0001213900-25-091096 | 7270 | ||||||
| 2025-09-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-002600 | 005-91228 | 251334480 | 34 | 55521 | |||
| 2025-09-19 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-25-089584 | 001-39138 | 251327306 | 34 | 951017 | 1 | 1 |
| 2025-09-19 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-089581 | 333-285914 | 251327292 | 33 | 800433 | |||
| 2025-09-18 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-089025 | 333-285914 | 251324038 | 33 | 804052 | |||
| 2025-08-13 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-25-075678 | 001-39138 | 251211680 | 34 | 323943 | 1 | 1 |
| 2025-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-25-075635 | 001-39138 | 251211282 | 34 | 5289132 | 1 | 1 | |
| 2025-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000475 | 005-91228 | 251190373 | 34 | 7938 | |||
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003206 | 005-91228 | 251132325 | 34 | 10864 | |||
| 2025-07-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-004068 | 005-91228 | 251118236 | 34 | 14124 | |||
| 2025-07-09 | 8-K | CURRENT REPORT | 2.05,5.02,8.01,9.01 | 0001213900-25-062194 | 001-39138 | 251112305 | 34 | 277027 | 1 | 1 |
| 2025-07-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-061632 | 001-39138 | 251106990 | 34 | 20227733 | 1 | 1 |
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061503 | 5700 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061501 | 5685 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061500 | 5721 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061498 | 5692 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061495 | 5666 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061493 | 5694 | ||||||
| 2025-07-03 | 4 | xslF345X05/ownership.xml | 0001213900-25-061492 | 5681 | ||||||
| 2025-07-03 | 8-K | CURRENT REPORT | 5.07 | 0001213900-25-061471 | 001-39138 | 251105498 | 34 | 255972 | 1 | 1 |
| 2025-06-16 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-054465 | 001-39138 | 251048487 | 34 | 19811726 | 1 | 1 |
| 2025-06-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-051729 | 5734 | ||||||
| 2025-06-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-051726 | 5736 | ||||||
| 2025-06-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-051724 | 5651 | ||||||
| 2025-06-06 | 4 | xslF345X05/ownership.xml | 0001213900-25-051722 | 5752 | ||||||
| 2025-05-19 | ARS | FORM ARS | 0001213900-25-045091 | 001-39138 | 25961551 | 34 | 978623 | |||
| 2025-05-19 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-045090 | 001-39138 | 25961544 | 34 | 3805879 | |||
| 2025-05-19 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-045086 | 001-39138 | 25961529 | 34 | 9767624 | 1 | 1 | |
| 2025-05-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-25-042017 | 001-39138 | 25934671 | 34 | 352060 | 1 | 1 |
| 2025-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-25-042011 | 001-39138 | 25934584 | 34 | 4725908 | 1 | 1 | |
| 2025-03-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000800 | 333-285914 | 25774989 | 33 | 1866 | ||
| 2025-03-26 | 424B5 | PROSPECTUS | 0001013762-25-002767 | 333-285914 | 25773968 | 33 | 175457 | |||
| 2025-03-24 | CORRESP | filename1.htm | 0001013762-25-001604 | 7212 | ||||||
| 2025-03-21 | UPLOAD | filename1.pdf | 0000000000-25-003070 | 333-285914 | 40221 | |||||
| 2025-03-19 | 8-K | CURRENT REPORT | 1.01,1.02,9.01 | 0001213900-25-025123 | 001-39138 | 25753340 | 34 | 257051 | 1 | 1 |
| 2025-03-19 | S-3 | REGISTRATION STATEMENT | 0001213900-25-025077 | 333-285914 | 25752824 | 33 | 1341361 | |||
| 2025-02-28 | 10-K | ANNUAL REPORT | 0001213900-25-018384 | 001-39138 | 25683220 | 34 | 8179067 | 1 | 1 | |
| 2025-02-27 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-25-017656 | 001-39138 | 25673135 | 34 | 340619 | 1 | 1 |
| 2025-02-18 | 4 | xslF345X05/ownership.xml | 0001213900-25-014951 | 5742 | ||||||
| 2025-02-18 | 4 | xslF345X05/ownership.xml | 0001213900-25-014950 | 5750 | ||||||
| 2025-02-18 | 4 | xslF345X05/ownership.xml | 0001213900-25-014949 | 5657 | ||||||
| 2025-02-18 | 4 | xslF345X05/ownership.xml | 0001213900-25-014948 | 5758 | ||||||
| 2025-02-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-012186 | 005-91228 | 25609658 | 34 | 31250 | |||
| 2025-01-08 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-001810 | 001-39138 | 25516568 | 34 | 18940824 | 1 | 1 |
| 2024-12-12 | 4 | xslF345X05/ownership.xml | 0001213900-24-108551 | 8922 | ||||||
| 2024-12-12 | 144 | xsl144X01/primary_doc.xml | 0001213900-24-108550 | 001-39138 | 241546467 | 33 | 5246 | |||
| 2024-11-14 | SC 13G/A | d11530244_13g-a.htm | 0000919574-24-006774 | 005-91228 | 241464867 | 34 | 178261 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-098328 | 005-91228 | 241461051 | 34 | 192378 | |||
| 2024-11-08 | SC 13G | us4718712023_110824.txt | 0002012383-24-003556 | 005-91228 | 241439690 | 34 | 13739 | |||
| 2024-11-07 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-24-095175 | 001-39138 | 241433230 | 34 | 338732 | 1 | 1 |
| 2024-11-07 | 10-Q | QUARTERLY REPORT | 0001213900-24-095173 | 001-39138 | 241433187 | 34 | 5295460 | 1 | 1 | |
| 2024-11-04 | SC 13G/A | SC 13G/A | 0001178913-24-003454 | 005-91228 | 241421810 | 34 | 89528 | |||
| 2024-10-22 | SC 13G | us4718712023_102224.txt | 0002012383-24-001610 | 005-91228 | 241387313 | 34 | 13729 | |||
| 2024-10-15 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-24-087394 | 001-39138 | 241368943 | 34 | 289245 | 1 | 1 |
| 2024-09-12 | 4 | xslF345X05/ownership.xml | 0001213900-24-078214 | 9409 | ||||||
| 2024-09-12 | 144 | xsl144X01/primary_doc.xml | 0001213900-24-078213 | 001-39138 | 241295777 | 33 | 5280 | |||
| 2024-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-24-067897 | 001-39138 | 241198719 | 34 | 6670637 | 1 | 1 | |
| 2024-06-20 | 4 | xslF345X05/ownership.xml | 0001213900-24-053989 | 5675 | ||||||
| 2024-06-20 | 3 | xslF345X02/ownership.xml | 0001213900-24-053987 | 9323 | ||||||
| 2024-06-20 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-24-053982 | 001-39138 | 241053941 | 34 | 287652 | 1 | 1 |
| 2024-06-12 | 4 | xslF345X05/ownership.xml | 0001213900-24-052215 | 15724 | ||||||
| 2024-06-12 | 144 | xsl144X01/primary_doc.xml | 0001213900-24-052213 | 001-39138 | 241039884 | 33 | 5209 | |||
| 2024-06-12 | 4 | xslF345X05/ownership.xml | 0001213900-24-052087 | 17398 | ||||||
| 2024-06-12 | 8-K | CURRENT REPORT | 5.02,5.07,9.01 | 0001213900-24-051891 | 001-39138 | 241037513 | 34 | 678600 | 1 | 1 |
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051417 | 11348 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051416 | 11524 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051414 | 11839 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051411 | 11751 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051409 | 11708 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051405 | 5188 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051401 | 11441 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001213900-24-051398 | 11998 | ||||||
| 2024-06-07 | S-8 POS | POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 0001213900-24-050849 | 333-277674 | 241030573 | 33 | 141972 | |||
| 2024-06-07 | S-8 POS | POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 0001213900-24-050843 | 333-270361 | 241030533 | 33 | 141972 | |||
| 2024-06-07 | S-8 POS | POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 0001213900-24-050838 | 333-263702 | 241030505 | 33 | 141972 | |||
| 2024-06-07 | S-8 | REGISTRATION STATEMENT | 0001213900-24-050751 | 333-280039 | 241029156 | 33 | 570919 | |||
| 2024-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-24-042805 | 001-39138 | 24942866 | 34 | 4777140 | 1 | 1 | |
| 2024-05-03 | DEFA14A | ADDITIONAL MATERIALS | 0001213900-24-039304 | 001-39138 | 24910678 | 34 | 41663 | |||
| 2024-04-22 | ARS | FORM ARS | 0001213900-24-034840 | 001-39138 | 24860720 | 34 | 865684 | |||
| 2024-04-22 | DEFA14A | ADDITIONAL MATERIALS | 0001213900-24-034831 | 001-39138 | 24860670 | 34 | 3755792 | |||
| 2024-04-22 | DEF 14A | PROXY STATEMENT | 0001213900-24-034820 | 001-39138 | 24860614 | 34 | 5437176 | |||
| 2024-03-27 | SC 13G | d11006439_13g.htm | 0000919574-24-002193 | 005-91228 | 24791139 | 34 | 226429 | |||
| 2024-03-12 | 4 | xslF345X05/ownership.xml | 0001213900-24-021961 | 10097 | ||||||
| 2024-03-12 | 144 | xsl144X01/primary_doc.xml | 0001213900-24-021952 | 001-39138 | 24744275 | 33 | 4590 | |||
| 2024-03-06 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000339 | 001-39138 | 24727334 | 33 | 4349 | |||
| 2024-03-05 | S-8 | REGISTRATION STATEMENT | 0001213900-24-020154 | 333-277674 | 24721697 | 33 | 96785 | |||
| 2024-03-05 | 10-K | ANNUAL REPORT | 0001213900-24-020114 | 001-39138 | 24720182 | 34 | 8864224 | 1 | 1 | |
| 2024-03-04 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-24-019249 | 001-39138 | 24712860 | 34 | 391490 | 1 | 1 |
| 2024-02-20 | 4 | xslF345X05/ownership.xml | 0001213900-24-015465 | 5718 | ||||||
| 2024-02-20 | 4 | xslF345X05/ownership.xml | 0001213900-24-015462 | 5724 | ||||||
| 2024-02-20 | 4 | xslF345X05/ownership.xml | 0001213900-24-015459 | 5639 | ||||||
| 2024-02-20 | 4 | xslF345X05/ownership.xml | 0001213900-24-015457 | 5748 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024111 | 005-91228 | 24641183 | 34 | 138088 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023696 | 005-91228 | 24638601 | 34 | 115284 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-24-000442 | 005-91228 | 24633219 | 34 | 266292 | |||
| 2024-02-12 | 4 | 4 | 0000950170-24-014017 | 41237 | ||||||
| 2024-02-12 | SC 13D/A | SC 13D/A | 0001193125-24-032344 | 005-91228 | 24621730 | 34 | 200438 | |||
| 2024-02-09 | 4 | OWNERSHIP DOCUMENT | 0000921895-24-000337 | 22116 | ||||||
| 2024-02-09 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-24-000336 | 005-91228 | 24617079 | 34 | 294826 | |||
| 2024-02-07 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-010661 | 333-271500 | 24601703 | 33 | 803817 | |||
| 2024-02-06 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-24-010267 | 001-39138 | 24598279 | 34 | 657624 | 1 | 1 |
| 2024-02-05 | SC 13G/A | SC 13G/A | 0001178913-24-000365 | 005-91228 | 24594240 | 34 | 89073 | |||
| 2024-02-02 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-009375 | 005-91228 | 24589068 | 34 | 156181 | |||
| 2024-01-04 | 8-K | CURRENT REPORT | 3.03,5.03,9.01 | 0001213900-24-000980 | 001-39138 | 24509697 | 34 | 295260 | 1 | 1 |
| 2024-01-02 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-24-000056 | 001-39138 | 24500298 | 34 | 280245 | 1 | 1 |
| 2023-12-20 | 8-K | CURRENT REPORT | 5.07,9.01 | 0001213900-23-097100 | 001-39138 | 231499331 | 34 | 264248 | 1 | 1 |
| 2023-11-30 | 4 | xslF345X05/ownership.xml | 0001213900-23-091458 | 4994 | ||||||
| 2023-11-22 | 4 | xslF345X05/ownership.xml | 0001213900-23-089579 | 4987 | ||||||
| 2023-11-20 | 4 | xslF345X05/ownership.xml | 0001213900-23-088896 | 8460 | ||||||
| 2023-11-20 | DEF 14A | PROXY STATEMENT | 0001213900-23-088825 | 001-39138 | 231423578 | 34 | 3793920 | |||
| 2023-11-09 | PRE 14A | PROXY STATEMENT | 0001213900-23-085198 | 001-39138 | 231392142 | 34 | 3795227 | |||
| 2023-11-09 | 10-Q | QUARTERLY REPORT | 0001213900-23-084970 | 001-39138 | 231390341 | 34 | 5302444 | 1 | 1 | |
| 2023-11-09 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-084938 | 001-39138 | 231390155 | 34 | 383576 | 1 | 1 |
| 2023-11-02 | 4 | xslF345X05/ownership.xml | 0001213900-23-082883 | 5480 | ||||||
| 2023-11-02 | 3 | xslF345X02/ownership.xml | 0001213900-23-082881 | 11345 | ||||||
| 2023-11-01 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-23-081941 | 001-39138 | 231366622 | 34 | 295445 | 1 | 1 |
| 2023-10-20 | 8-K | CURRENT REPORT | 3.01 | 0001013762-23-005230 | 001-39138 | 231335906 | 34 | 264327 | 1 | 1 |
| 2023-10-13 | 4 | xslF345X05/ownership.xml | 0001013762-23-003903 | 4960 | ||||||
| 2023-10-13 | 4 | xslF345X05/ownership.xml | 0001013762-23-003902 | 4952 | ||||||
| 2023-10-13 | 4 | xslF345X05/ownership.xml | 0001013762-23-003901 | 5380 | ||||||
| 2023-10-13 | 144 | xsl144X01/primary_doc.xml | 0001013762-23-003900 | 001-39138 | 231325956 | 33 | 4455 | |||
| 2023-10-10 | SC 13G | SC 13G | 0001178913-23-003298 | 005-91228 | 231316615 | 34 | 93232 | |||
| 2023-10-10 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-081286 | 001-39138 | 231315598 | 34 | 10483563 | 1 | 1 |
| 2023-10-10 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-081265 | 001-39138 | 231315517 | 34 | 285868 | 1 | 1 |
| 2023-09-26 | 4 | xslF345X05/ownership.xml | 0001213900-23-079569 | 5561 | ||||||
| 2023-09-26 | 3 | xslF345X02/ownership.xml | 0001213900-23-079563 | 9936 | ||||||
| 2023-09-25 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-23-078927 | 001-39138 | 231273149 | 34 | 287029 | 1 | 1 |
| 2023-09-21 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-078145 | 001-39138 | 231267779 | 34 | 290035 | 1 | 1 |
| 2023-08-11 | S-8 | REGISTRATION STATEMENT | 0001213900-23-066283 | 333-273941 | 231164737 | 33 | 103429 | |||
| 2023-08-11 | 10-Q | QUARTERLY REPORT | 0001213900-23-066234 | 001-39138 | 231164067 | 34 | 5201784 | 1 | 1 | |
| 2023-08-11 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-066233 | 001-39138 | 231164017 | 34 | 349227 | 1 | 1 |
| 2023-06-20 | 4 | xslF345X04/ownership.xml | 0001213900-23-050220 | 5615 | ||||||
| 2023-06-20 | 3 | xslF345X02/ownership.xml | 0001213900-23-050219 | 9816 | ||||||
| 2023-06-20 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-23-050029 | 001-39138 | 231024958 | 34 | 309835 | 1 | 1 |
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001213900-23-048688 | 001-39138 | 231012802 | 33 | 4511 | |||
| 2023-06-13 | 4 | xslF345X04/ownership.xml | 0001213900-23-048683 | 9513 | ||||||
| 2023-06-13 | 4 | xslF345X04/ownership.xml | 0001213900-23-048681 | 5661 | ||||||
| 2023-06-13 | 3 | xslF345X02/ownership.xml | 0001213900-23-048680 | 9327 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047574 | 5219 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047573 | 5263 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047571 | 5238 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047570 | 5274 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047569 | 5245 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047568 | 5256 | ||||||
| 2023-06-08 | 4 | xslF345X04/ownership.xml | 0001213900-23-047567 | 5261 | ||||||
| 2023-06-08 | 8-K | CURRENT REPORT | 5.02,5.03,5.07,9.01 | 0001213900-23-047446 | 001-39138 | 231001852 | 34 | 430264 | 1 | 1 |
| 2023-06-02 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-23-045834 | 001-39138 | 23989984 | 34 | 8424805 | 1 | 1 |
| 2023-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-23-039021 | 001-39138 | 23915768 | 34 | 4805387 | 1 | 1 | |
| 2023-05-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-038997 | 001-39138 | 23915551 | 34 | 355843 | 1 | 1 |
| 2023-05-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-05 16:30:00 | 9999999995-23-001326 | 333-271500 | 23895715 | 33 | 1824 | ||
| 2023-05-05 | 424B5 | PROSPECTUS | 0001213900-23-036926 | 333-271500 | 23894557 | 33 | 210635 | |||
| 2023-05-03 | CORRESP | filename1.htm | 0001213900-23-036051 | 7704 | ||||||
| 2023-05-02 | UPLOAD | filename1.pdf | 0000000000-23-004531 | 40356 | ||||||
| 2023-04-28 | S-3 | REGISTRATION STATEMENT | 0001213900-23-033846 | 333-271500 | 23865687 | 33 | 1191937 | |||
| 2023-04-21 | ARS | FORM ARS | 0001213900-23-031678 | 001-39138 | 23836337 | 34 | 2590853 | |||
| 2023-04-21 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-031676 | 001-39138 | 23836295 | 34 | 988929 | |||
| 2023-04-21 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-23-031673 | 001-39138 | 23836259 | 34 | 1155337 | |||
| 2023-04-14 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000012 | 001-39138 | 23821485 | 33 | 4229 | |||
| 2023-04-14 | 4 | xslF345X04/ownership.xml | 0001213900-23-029901 | 4939 | ||||||
| 2023-04-14 | 4 | OWNERSHIP DOCUMENT | 0001213900-23-029900 | 4946 | ||||||
| 2023-04-14 | 4 | OWNERSHIP DOCUMENT | 0001213900-23-029896 | 4977 | ||||||
| 2023-04-14 | 4 | OWNERSHIP DOCUMENT | 0001213900-23-029893 | 5074 | ||||||
| 2023-04-14 | 4 | xslF345X04/ownership.xml | 0001213900-23-029888 | 4930 | ||||||
| 2023-04-14 | 8-K | CURRENT REPORT | 1.01,5.02,9.01 | 0001213900-23-029872 | 001-39138 | 23821139 | 34 | 285620 | 1 | 1 |
| 2023-04-13 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000008 | 001-39138 | 23819170 | 33 | 4217 | |||
| 2023-04-13 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000003 | 001-39138 | 23818060 | 33 | 4202 | |||
| 2023-04-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-024058 | 9772 | ||||||
| 2023-04-10 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-23-028579 | 001-39138 | 23811122 | 34 | 1153703 | |||
| 2023-03-20 | 4 | PRIMARY DOCUMENT | 0001213900-23-021494 | 5776 | ||||||
| 2023-03-20 | 4 | PRIMARY DOCUMENT | 0001213900-23-021493 | 5705 | ||||||
| 2023-03-08 | S-8 | REGISTRATION STATEMENT | 0001213900-23-018584 | 333-270361 | 23716694 | 33 | 115881 | |||
| 2023-03-08 | 10-K | ANNUAL REPORT | 0001213900-23-018542 | 001-39138 | 23716239 | 34 | 8278022 | 1 | 1 | |
| 2023-03-08 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-23-018537 | 001-39138 | 23716161 | 34 | 366248 | 1 | 1 |
| 2023-02-27 | 3/A | xslF345X02/ownership.xml | 0001213900-23-014976 | 3916 | ||||||
| 2023-02-27 | SC 13D | SCHEDULE 13D | 0000921895-23-000611 | 005-91228 | 23674732 | 34 | 326388 | |||
| 2023-02-17 | 4 | xslF345X03/ownership.xml | 0001213900-23-012598 | 5538 | ||||||
| 2023-02-17 | 3 | xslF345X02/ownership.xml | 0001213900-23-012597 | 9151 | ||||||
| 2023-02-17 | 8-K | CURRENT REPORT | 5.02,5.03,7.01,8.01,9.01 | 0001213900-23-012596 | 001-39138 | 23640367 | 34 | 528274 | 1 | 1 |
| 2023-02-16 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-012446 | 001-39138 | 23638548 | 34 | 283377 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020827 | 005-91228 | 23622797 | 34 | 137039 | |||
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001104659-23-019776 | 005-91228 | 23619363 | 34 | 65533 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-032630 | 005-91228 | 23612195 | 34 | 27707 | |||
| 2023-02-06 | SC 13G | THE SCHEDULE 13G | 0000921895-23-000300 | 005-91228 | 23591238 | 34 | 285655 | |||
| 2023-02-03 | 3 | OWNERSHIP DOCUMENT | 0000921895-23-000278 | 25583 | ||||||
| 2023-02-03 | 4 | xslF345X03/ownership.xml | 0001213900-23-007992 | 5607 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-003059 | 20750 | ||||||
| 2023-01-31 | SC 13D/A | SC 13D/A | 0001193125-23-020358 | 005-91228 | 23572749 | 34 | 190699 | |||
| 2023-01-30 | SC 13G | SC 13G | 0001193125-23-019178 | 005-91228 | 23568716 | 34 | 106939 | |||
| 2023-01-27 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000214 | 005-91228 | 23564004 | 34 | 280159 | |||
| 2023-01-27 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-23-005582 | 001-39138 | 23561412 | 34 | 282568 | 1 | 1 |
| 2023-01-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-007094 | 7702 | ||||||
| 2023-01-25 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-23-005155 | 001-39138 | 23552933 | 34 | 597652 | 1 | 1 |
| 2023-01-25 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-23-005150 | 333-267777 | 23552906 | 33 | 840549 | |||
| 2023-01-24 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-23-004850 | 333-267777 | 23548408 | 33 | 853299 | |||
| 2023-01-24 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-004843 | 001-39138 | 23548380 | 34 | 12447188 | 1 | 1 |
| 2023-01-19 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-23-003597 | 001-39138 | 23535945 | 34 | 256974 | 1 | 1 |
| 2023-01-13 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-002591 | 001-39138 | 23527296 | 34 | 297631 | 1 | 1 |
| 2023-01-10 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-001835 | 001-39138 | 23519703 | 34 | 6115612 | 1 | 1 |
| 2022-11-10 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-22-071292 | 001-39138 | 221378352 | 34 | 273978 | 1 | 1 |
| 2022-11-10 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-22-071291 | 333-267777 | 221378348 | 33 | 818042 | |||
| 2022-11-10 | 10-Q | QUARTERLY REPORT | 0001213900-22-071165 | 001-39138 | 221377197 | 34 | 6192477 | 1 | 1 | |
| 2022-11-10 | 8-K | CURRENT REPRT | 2.02,9.01 | 0001213900-22-071153 | 001-39138 | 221377062 | 34 | 336398 | 1 | 1 |
| 2022-11-04 | 8-K | CURRENT REPORT | 3.01 | 0001213900-22-069368 | 001-39138 | 221362242 | 34 | 256122 | 1 | 1 |
| 2022-10-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-10-18 16:30:00 | 9999999995-22-003076 | 333-267777 | 221317151 | 33 | 1825 | ||
| 2022-10-18 | 424B3 | PROSPECTUS | 0001213900-22-064405 | 333-260306 | 221314536 | 33 | 430522 | |||
| 2022-10-14 | CORRESP | filename1.htm | 0001213900-22-064076 | 7890 | ||||||
| 2022-10-13 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001213900-22-062795,2022-10-13 | 9999999995-22-003029 | 333-260306 | 221310171 | 33 | 1838 | ||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063949 | 4969 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063947 | 4960 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063945 | 5202 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063943 | 4973 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063941 | 5064 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063938 | 4942 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063936 | 4953 | ||||||
| 2022-10-13 | 4 | xslF345X03/ownership.xml | 0001213900-22-063934 | 4958 | ||||||
| 2022-10-13 | UPLOAD | filename1.pdf | 0000000000-22-011268 | 40324 | ||||||
| 2022-10-07 | POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 | 0001213900-22-062795 | 333-260306 | 221300829 | 33 | 521085 | |||
| 2022-10-07 | S-3 | REGISTRATION STATEMENT | 0001213900-22-062792 | 333-267777 | 221300807 | 33 | 940319 | |||
| 2022-08-12 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-22-047390 | 333-260306 | 221160034 | 33 | 1274373 | |||
| 2022-08-12 | 10-Q | QUARTERLY REPORT | 0001213900-22-047382 | 001-39138 | 221159940 | 34 | 5626306 | 1 | 1 | |
| 2022-08-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-22-047374 | 001-39138 | 221159880 | 34 | 364533 | 1 | 1 |
| 2022-08-11 | 3 | FORM 3 SUBMISSION | 0000899243-22-028389 | 20444 | ||||||
| 2022-08-11 | SC 13D/A | SC 13D/A | 0001193125-22-218630 | 005-91228 | 221156587 | 34 | 228867 | |||
| 2022-06-28 | 4 | xslF345X03/ownership.xml | 0001213900-22-035570 | 7376 | ||||||
| 2022-06-27 | 8-K | CURRENT REPORT | 5.07,9.01 | 0001213900-22-035178 | 001-39138 | 221044489 | 34 | 262111 | 1 | 1 |
| 2022-05-12 | 424B3 | PROSPECTUS SUPPLEMENT NO. 1 | 0001213900-22-025949 | 333-260306 | 22917994 | 33 | 1189711 | |||
| 2022-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-22-025945 | 001-39138 | 22917899 | 34 | 5292160 | 1 | 1 | |
| 2022-05-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-22-025933 | 001-39138 | 22917726 | 34 | 329002 | 1 | 1 |
| 2022-04-29 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-22-022712 | 001-39138 | 22875109 | 34 | 30010 | |||
| 2022-04-29 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-22-022704 | 001-39138 | 22875042 | 34 | 4267918 | |||
| 2022-04-28 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-022301 | 005-91228 | 22867053 | 34 | 74026 | |||
| 2022-04-27 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-22-021894 | 001-39138 | 22859427 | 34 | 4861007 | 1 | 1 |
| 2022-04-08 | 4 | xslF345X03/ownership.xml | 0001213900-22-018928 | 5692 | ||||||
| 2022-04-01 | 424B3 | PROSPECTUS | 0001213900-22-017515 | 333-260306 | 22799232 | 33 | 13785003 | |||
| 2022-03-29 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001213900-22-014845,2022-03-29 | 9999999995-22-000752 | 333-260306 | 22783084 | 33 | 1837 | ||
| 2022-03-24 | POS AM | POST EFFECTIVE REGISTRATION STATEMENT | 0001213900-22-014845 | 333-260306 | 22766561 | 33 | 30186178 | 1 | 1 | |
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014572 | 5596 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014570 | 5579 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014569 | 6947 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014568 | 5670 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014567 | 5590 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014565 | 8065 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014564 | 5561 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014562 | 12480 | ||||||
| 2022-03-23 | 4 | xslF345X03/ownership.xml | 0001213900-22-014561 | 5577 | ||||||
| 2022-03-23 | 4 | xslF345X03/jasper_fm4mar212022.xml | 0000905718-22-000484 | 7740 | ||||||
| 2022-03-22 | S-8 | REGISTRATION STATEMENT | 0001213900-22-014221 | 333-263773 | 22760801 | 33 | 312265 | |||
| 2022-03-21 | 3 | xslF345X02/ownership.xml | 0001213900-22-013883 | 9209 | ||||||
| 2022-03-21 | 8-K | CURRENT REPORT | 5.02,7.01,9.01 | 0001213900-22-013743 | 001-39138 | 22754280 | 34 | 286069 | 1 | 1 |
| 2022-03-18 | S-8 | REGISTRATION STATEMENT | 0001213900-22-013605 | 333-263702 | 22752953 | 33 | 221172 | |||
| 2022-03-18 | 10-K | ANNUAL REPORT | 0001213900-22-013592 | 001-39138 | 22752734 | 34 | 11401110 | 1 | 1 | |
| 2022-03-18 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-22-013584 | 001-39138 | 22752571 | 34 | 342826 | 1 | 1 |
| 2022-03-16 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-22-012935 | 001-39138 | 22744836 | 34 | 382897 | 1 | 1 |
| 2022-03-16 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-22-012682 | 001-39138 | 22743216 | 34 | 1992322 | 1 | 1 |
| 2022-03-11 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-22-011854 | 001-39138 | 22733039 | 34 | 302753 | 1 | 1 |
| 2022-02-28 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-22-009585 | 001-39138 | 22683966 | 34 | 376056 | 1 | 1 |
| 2022-02-25 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-22-009272 | 001-39138 | 22673629 | 34 | 296674 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-040222 | 005-91228 | 22626816 | 34 | 40135 | |||
| 2022-02-14 | SC 13G/A | JASPER THERAPEUTICS, INC. | 0001104659-22-021372 | 005-91228 | 22624895 | 34 | 140047 | |||
| 2022-02-11 | SC 13G/A | amch13ga.htm | 0000935836-22-000098 | 005-91228 | 22622444 | 34 | 67281 | |||
| 2022-02-03 | SC 13G/A | formsc13ga.htm | 0001493152-22-003080 | 005-91228 | 22587643 | 34 | 184104 | |||
| 2021-11-12 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-21-058780 | 333-260306 | 211404838 | 33 | 2222142 | |||
| 2021-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-21-058660 | 001-39138 | 211403321 | 34 | 8073429 | 1 | 1 | |
| 2021-11-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001213900-21-058658 | 001-39138 | 211403209 | 34 | 334047 | 1 | 1 |
| 2021-10-29 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-21-055432 | 333-260306 | 211363360 | 33 | 82073 | |||
| 2021-10-29 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-21-055431 | 001-39138 | 211363345 | 34 | 305419 | 1 | 1 |
| 2021-10-26 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-10-26 16:00:00 | 9999999995-21-004047 | 333-260306 | 211350518 | 33 | 1825 | ||
| 2021-10-26 | 424B3 | PROSPECTUS | 0001213900-21-054629 | 333-260306 | 211348769 | 33 | 18913964 | |||
| 2021-10-22 | CORRESP | filename1.htm | 0001213900-21-054174 | 13555 | ||||||
| 2021-10-22 | UPLOAD | filename1.pdf | 0000000000-21-012838 | 40314 | ||||||
| 2021-10-18 | S-1 | REGISTRATION STATEMENT | 0001213900-21-053099 | 333-260306 | 211326946 | 33 | 49495075 | 1 | 1 | |
| 2021-10-04 | SC 13G | SCHEDULE 13G | 0001013762-21-000084 | 005-91228 | 211303325 | 34 | 107526 | |||
| 2021-10-04 | SC 13D | SC 13D | 0000905718-21-001266 | 005-91228 | 211302815 | 34 | 73516 | |||
| 2021-10-04 | SC 13G | JASPER THERAPEUTICS, INC. | 0001104659-21-122496 | 005-91228 | 211302668 | 34 | 140355 | |||
| 2021-10-04 | SC 13G | d8979895_13g.htm | 0000919574-21-006093 | 005-91228 | 211302551 | 34 | 124112 | |||
| 2021-10-04 | 3 | OWNERSHIP DOCUMENT | 0001104659-21-122334 | 6547 | ||||||
| 2021-10-04 | SC 13G | SC 13G | 0001104659-21-122325 | 005-91228 | 211301158 | 34 | 67605 | |||
| 2021-10-01 | SC 13G | SC 13G | 0001193125-21-289912 | 005-91228 | 211300102 | 34 | 27884 | |||
| 2021-10-01 | 3 | xslF345X02/jasper_fm3sep242021.xml | 0000905718-21-001263 | 6119 | ||||||
| 2021-10-01 | SC 13G | SCHEDULE 13G | 0001213900-21-051114 | 005-91228 | 211299040 | 34 | 93686 | |||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051112 | 12698 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051111 | 9295 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051109 | 10711 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051107 | 11394 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051106 | 11345 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051105 | 9271 | ||||||
| 2021-10-01 | 3 | OWNERSHIP DOCUMENT | 0001213900-21-051104 | 12254 | ||||||
| 2021-10-01 | 3 | OWNERSHIP DOCUMENT | 0001213900-21-051103 | 9322 | ||||||
| 2021-10-01 | 3 | xslF345X02/ownership.xml | 0001213900-21-051101 | 7530 | ||||||
| 2021-09-29 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 3.03,5.03,5.05,9.01 | 0001213900-21-050602 | 001-39138 | 211292295 | 34 | 326125 | 1 | 1 |
| 2021-09-29 | 8-K | CURRENT REPORT | 1.01,2.01,3.02,4.01,5.01,5.02,5.06,7.01,9.01 | 0001213900-21-050592 | 001-39138 | 211292166 | 34 | 2149641 | 1 | 1 |
| 2021-09-28 | 4 | OWNERSHIP DOCUMENT | 0001213900-21-050332 | 11144 | ||||||
| 2021-09-28 | 4 | xslF345X03/ownership.xml | 0001213900-21-050330 | 11073 | ||||||
| 2021-09-28 | 4 | xslF345X03/ownership.xml | 0001213900-21-050329 | 11166 | ||||||
| 2021-09-28 | 4 | OWNERSHIP DOCUMENT | 0001213900-21-050322 | 10467 | ||||||
| 2021-09-27 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-21-001079 | 001-39138 | 211281526 | 34 | 2967 | |||
| 2021-09-23 | 8-K | CURRENT REPORT | 5.07,8.01,9.01 | 0001213900-21-049423 | 001-39138 | 211270731 | 34 | 375368 | 1 | 1 |
| 2021-09-20 | 425 | CURRENT REPORT | 0001213900-21-048848 | 001-39138 | 211263548 | 34 | 83453 | |||
| 2021-09-20 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-21-048846 | 001-39138 | 211263527 | 34 | 335460 | 1 | 1 |
| 2021-09-17 | SC 13G | amplitudehealthcare13g.htm | 0000935836-21-000520 | 005-91228 | 211260997 | 34 | 69055 | |||
| 2021-09-09 | 425 | CURRENT REPORT | 0001213900-21-047219 | 001-39138 | 211244837 | 34 | 6144510 | |||
| 2021-09-09 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-21-047217 | 001-39138 | 211244789 | 34 | 6413154 | 1 | 1 |
| 2021-09-08 | 425 | FORM 425 | 0001213900-21-047034 | 001-39138 | 211242232 | 34 | 35174 | |||
| 2021-08-27 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004598 | 274373 | ||||||
| 2021-08-26 | EFFECT | xslEFFECTX01/primary_doc.xml | S-4,,2021-08-26 16:00:00 | 9999999995-21-003323 | 333-256875 | 211214014 | 33 | 1742 | ||
| 2021-08-26 | 424B3 | PROSPECTUS | 0001213900-21-045109 | 333-256875 | 211213418 | 33 | 25525144 | |||
| 2021-08-25 | S-4/A | REGISTRATION STATEMENT | 0001213900-21-044732 | 333-256875 | 211205066 | 33 | 45431753 | 1 | 1 | |
| 2021-08-24 | CORRESP | filename1.htm | 0001213900-21-044643 | 8217 | ||||||
| 2021-08-24 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004583 | 276092 | ||||||
| 2021-08-20 | CORRESP | filename1.htm | 0001213900-21-044103 | 11450 | ||||||
| 2021-08-20 | S-4/A | REGISTRATION STATEMENT | 0001213900-21-044097 | 333-256875 | 211194580 | 33 | 46172422 | 1 | 1 | |
| 2021-08-17 | UPLOAD | filename1.pdf | 0000000000-21-010049 | 44641 | ||||||
| 2021-08-16 | 10-Q | QUARTERLY REPORT | 0001213900-21-043115 | 001-39138 | 211179566 | 34 | 3129542 | 1 | 1 | |
| 2021-08-09 | S-4/A | REGISTRATION STATEMENT | 0001213900-21-040851 | 333-256875 | 211154381 | 33 | 37869873 | 1 | ||
| 2021-08-06 | CORRESP | filename1.htm | 0001213900-21-040853 | 16701 | ||||||
| 2021-08-05 | UPLOAD | filename1.pdf | 0000000000-21-009606 | 39887 | ||||||
| 2021-08-03 | UPLOAD | filename1.pdf | 0000000000-21-009531 | 46038 | ||||||
| 2021-07-23 | 10-Q/A | AMENDMENT NO. 2 TO FORM 10-Q | 0001213900-21-038236 | 001-39138 | 211108825 | 34 | 90394 | |||
| 2021-07-22 | CORRESP | filename1.htm | 0001213900-21-038237 | 11341 | ||||||
| 2021-07-22 | UPLOAD | filename1.pdf | 0000000000-21-009061 | 43009 |
One latest value per concept from companyfacts (477 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 1.11M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 74.80M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-04-30 | 0001213900-26-050178 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | -2.08M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-15 | 0001213900-26-068765 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.37M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-15 | 0001213900-26-068765 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | -3.54M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-15 | 0001213900-26-068765 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 2.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-15 | 0001213900-26-068765 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | -77 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-15 | 0001213900-26-068765 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 13,837.11 | 2026-10-13 | S-3 | 2026-10-14 | 0001213900-26-109479 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 13,837.11 | 2026-10-13 | S-3 | 2026-10-14 | 0001213900-26-109479 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 159.05M | 2026-10-13 | S-3 | 2026-10-14 | 0001213900-26-109479 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-13 | S-3 | 2026-10-14 | 0001213900-26-109479 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-13 | S-3 | 2026-10-14 | 0001213900-26-109479 | |||
| ffd | TtlTxValtn | TtlTxValtn | USD | 4.00M | 2026-10-07 | SC TO-I | 2026-10-07 | 0001213900-26-107397 | |||
| us-gaap | AccountsNotesAndLoansReceivableNetCurrent | Accounts and Financing Receivable, after Allowance for Credit Loss, Current | USD | 8.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 103,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilities | Accounts Payable and Other Accrued Liabilities | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 10.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 3.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccountsPayableCurrentAndNoncurrent | Accounts Payable | USD | 100,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 8.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccruedIncomeTaxes | Accrued Income Taxes | USD | 200,000 | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 5.50M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.50M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058660 | |
| us-gaap | AccruedLiabilitiesFairValueDisclosure | Accrued Liabilities, Fair Value Disclosure | USD | 400,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | AccruedPayrollTaxesCurrent | Accrued Payroll Taxes, Current | USD | 24,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AccumulatedCapitalizedInterestCosts | Accumulated Capitalized Interest Costs | USD | 135.50M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 3.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AdditionalLiabilityLongDurationInsuranceReinsuranceRecoverableAfterAllowance | AdditionalLiabilityLongDurationInsuranceReinsuranceRecoverableAfterAllowance | USD | 400,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 324.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | -1.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 9,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 1.19M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 725,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | AdministrativeFeesExpense | Administrative Fees Expense | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | AdvanceRoyalties | Advance Royalties | USD | 150.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.19M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 100,000 | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 846,591 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | AreaOfLand | Area of Land | sqft | 25,900 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 | |
| us-gaap | Assets | Assets | USD | 147.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 147.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | AssetsFairValueAdjustment | Assets, Fair Value Adjustment | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 102.87M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | AssetsHeldInTrustNoncurrent | Assets Held-in-trust, Noncurrent | USD | 100.34M | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | AssetsNet | Net Assets | USD | 600,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 5.30M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | BusinessAcquisitionSharePrice | Business Acquisition, Share Price | USD/shares | 9.2 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment | USD | 5.00M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage | pure | 0.6 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | CapitalizedComputerSoftwareGross | Capitalized Computer Software, Gross | USD | 170,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | CapitalizedComputerSoftwareNet | Capitalized Computer Software, Net | USD | 90,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | CapitalUnitsOutstanding | Capital Units, Outstanding | shares | 1.18M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | Cash | Cash | USD | 700,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 135.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 1.00M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -155,560 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-13 | 0001213900-20-012038 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 135.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 106.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -460,384 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 115.81M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight | Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares | 10 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001213900-25-075635 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 675,000 | 2025-09-30 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 20.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonStockDividendsPerShareCashPaid | Common Stock, Dividends, Per Share, Cash Paid | USD/shares | 0.04 | 2018-03-01 | 2018-03-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | CommonStockDividendsShares | Common Stock Dividends, Shares | shares | 2.26M | 2018-03-01 | 2018-03-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | CommonStockHeldBySubsidiary | Common Stock Held by Subsidiary | USD | 30.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 15.12 | 2021-09-24 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | CommonStockOtherSharesOutstanding | Common Stock, Other Shares, Outstanding | shares | 5.00M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 492.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonStockSharesSubscribedButUnissued | Common Stock, Shares Subscribed but Unissued | shares | 110.80M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | CommonUnitIssued | Common Unit, Issued | shares | 12,999 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | CompensationExpenseExcludingCostOfGoodAndServiceSold | Compensation Expense, Excluding Cost of Good and Service Sold | USD | 100,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 12,953 | 2026-07-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 2.34M | 2023-01-31 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 61 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 | |
| us-gaap | CostMaintenance | Cost, Maintenance | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 11.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | CreditDerivativeLiquidationProceedsPercentage | Credit Derivative, Liquidation Proceeds, Percentage | pure | 0.6 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001213900-20-036217 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 38,451 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -48,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001213900-20-036217 |
| us-gaap | DebtConversionConvertedInstrumentRate | Debt Conversion, Converted Instrument, Rate | pure | 0.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 300,000 | 2019-08-23 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.09 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | DebtInstrumentRedemptionPricePercentage | Debt Instrument, Redemption Price, Percentage | pure | 0.08 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | DeferredCompensationArrangementWithIndividualCompensationExpense | Deferred Compensation Arrangement with Individual, Compensation Expense | USD | 986,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | DeferredCostsAndOtherAssets | Deferred Costs and Other Assets | USD | 193,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -14.97M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 444,772 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 105,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredLongTermLiabilityCharges | Deferred Long-term Liability Charges | USD | 600,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 75.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | DeferredOtherTaxExpenseBenefit | Deferred Other Tax Expense (Benefit) | USD | 327,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -2,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 286,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 77.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 7.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 19.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 12,389 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001213900-20-007505 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 105,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 48.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 1.00M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 600,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 614,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 21,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DeferredTaxAssetsStateTaxes | Deferred Tax Assets, State Taxes | USD | 4.52M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 2.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 542,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 1.30M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 242,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 16.20M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 2.70M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 28,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 13,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant | Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds | Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds | USD | 4.50M | 2023-01-31 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | Deposits | Deposits | USD | 100,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058660 | |
| us-gaap | Depreciation | Depreciation | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 59,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.11M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | DerivativeAssetsLiabilitiesAtFairValueNet | Derivative Assets (Liabilities), at Fair Value, Net | USD | 18,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | DerivativeCashReceivedOnHedge | Derivative, Cash Received on Hedge | USD | 6,000 | 2018-03-01 | 2018-03-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | DerivativeFairValueOfDerivativeNet | Derivative, Fair Value, Net | USD | 735,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | DerivativeInstrumentsInHedgesLiabilitiesAtFairValue | Derivative Instruments in Hedges, Liabilities, at Fair Value | USD | 4.30M | 2019-11-30 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 8.16M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 2.26M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | DirectTaxesAndLicensesCosts | Cost, Direct Tax and License | USD | 25,000 | 2023-03-01 | 2023-03-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | DisaggregationOfIncomeStatementExpenseCaptionReimbursementToAnotherEntityAmount | DisaggregationOfIncomeStatementExpenseCaptionReimbursementToAnotherEntityAmount | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | DividendsStock | Dividends, Stock | USD | 2.659 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | DueToEmployeesCurrentAndNoncurrent | Due to Employees | USD | 74,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | DueToOtherRelatedPartiesNoncurrent | Due to Other Related Parties, Noncurrent | USD | 6,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -14.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2.69 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -14.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.006 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.235 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.192 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDeductions | Effective Income Tax Rate Reconciliation, Deduction, Percent | pure | 0.8 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.016 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 100,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 95,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 100,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 3.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions | Share-based Payment Arrangement, Exercise of Option, Tax Benefit | USD | 100,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation | Employee Stock Ownership Plan (ESOP), Fair Value of Shares Subject to Repurchase Obligation | USD | 855,173 | 2023-04-01 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 | |
| us-gaap | EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent | EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent | USD | 200,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | EquipmentExpense | Equipment Expense | USD | 1.71M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | EquityFairValueAdjustment | Equity, Fair Value Adjustment | USD | 700,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.099 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001213900-22-025945 | |
| us-gaap | EquityMethodInvestmentQuotedMarketValue | Equity Method Investment, Quoted Market Value | USD | 200,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 263.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | ExcessStockSharesAuthorized | Excess Stock, Shares Authorized | shares | 490.00M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | ExcessStockSharesIssued | Excess Stock, Shares Issued | shares | 9.00M | 2023-01-31 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ExcessStockSharesOutstanding | Excess Stock, Shares Outstanding | shares | 1.70M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001213900-22-025945 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -12.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | FairValueNetAssetLiability | Fair Value, Net Asset (Liability) | USD | 28,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | FinanceLeaseRightOfUseAssetAccumulatedAmortization | Finance Lease, Right-of-Use Asset, Accumulated Amortization | USD | 105,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | ForeignCurrencyTransactionGainLossAfterTax | ForeignCurrencyTransactionGainLossAfterTax | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 502,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | GainLossOnFairValueHedgesRecognizedInEarnings | Gain (Loss) on Fair Value Hedges Recognized in Earnings | USD | 100,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | GainLossOnSaleOfProperties | Gain (Loss) on Sale of Properties | USD | 100,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 105,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 15.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 1.90M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 1.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 1.93M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 5,170 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 250,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 2,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 17.81M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 32,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -15.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 26,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 1.63M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncomeTaxReconciliationTaxSettlementsStateAndLocal | Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount | USD | -2,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | -663,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -6.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 59,477 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -4.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets | Increase (Decrease) in Accounts Receivable and Other Operating Assets | USD | -663,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 56,628 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -4.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 3.50M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | -911,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-12 | 0001213900-22-047382 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -32,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -143,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -80,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -663,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -11.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 1.36M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | -1.47M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | IncreaseDecreaseInPrepaidTaxes | Increase (Decrease) in Prepaid Taxes | USD | 5,071 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -600,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 2.53M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | InterestCostsIncurred | Interest Costs Incurred | USD | 300,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -246,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 1.39M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 |
| us-gaap | InterestIncomeSecuritiesTaxable | Interest Income, Securities, Operating, Taxable | USD | 2.20M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | InvestmentInterestRate | Investment Interest Rate | pure | 0.25 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 2.48M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 71,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 743,000 | 2022-12-31 | 2022 | Q2 | 10-Q | 2022-08-12 | 0001213900-22-047382 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 32,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 743,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 740,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 740,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 740,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 39,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | Liabilities | Liabilities | USD | 20.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 147.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 13.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LiabilitiesFairValueAdjustment | Liabilities, Fair Value Adjustment | USD | 18,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | LiabilitiesOtherThanLongtermDebtNoncurrent | Liabilities, Other than Long-term Debt, Noncurrent | USD | 600,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | LinesOfCreditCurrent | Line of Credit, Current | USD | 400,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | LoansAndLeasesReceivableAllowance | Loans and Leases Receivable, Allowance | USD | 1.20M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 1.97M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 3.40M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 100.13M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 102.87M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 125.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 7.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -26.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -148.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NetIncomeLossAttributableToNonredeemableNoncontrollingInterest | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | USD | 1.93M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | 24.50M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -47.96M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001213900-25-075635 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -30.34M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | USD | -6.48M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted | Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax | USD/shares | -1.03 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 16,000 | 2024-01-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | NondebtorReorganizationItemsLegalAndAdvisoryProfessionalFees | Nondebtor Reorganization Items, Legal and Advisory Professional Fees | USD | 300,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-12 | 0001213900-22-047382 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 300,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001213900-25-075635 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 15.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NotesPayableRelatedPartiesCurrentAndNoncurrent | Notes Payable, Related Parties | USD | 183,876 | 2019-08-23 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056595 |
| us-gaap | OfferingCostsPartnershipInterests | Offering Costs, Partnership Interests | USD | 5.71M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-24 | 0001213900-21-028790 | |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 172.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 172.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -164.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 609,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 400,000 | 2025-12-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingLeaseLeaseIncomeLeasePayments | Operating Lease, Lease Income, Lease Payments | USD | 1.12M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 69,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 69,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 724,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 67,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 201,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.093 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 2.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | OptionContractIndexedToEquitySettlementCashEffectOfChangeInFairValueOfShare | OptionContractIndexedToEquitySettlementCashEffectOfChangeInFairValueOfShare | USD | 100,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 | |
| us-gaap | OptionContractIndexedToEquitySettlementShareFairValue | OptionContractIndexedToEquitySettlementShareFairValue | USD | 1.50M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 102,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 100,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 636,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 18,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OtherCashEquivalentsAtCarryingValue | Other Cash Equivalents, at Carrying Value | USD | 1.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 400,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | OtherDepreciationAndAmortization | Other Depreciation and Amortization | USD | 500,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 1.81M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | OtherIncome | Other Income | USD | 2.30M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OtherIntangibleAssetsNet | Other Intangible Assets, Net | USD | 5.00M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | OtherInterestEarningAssets | Other Interest Earning Assets | USD | 198,343 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 28,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | OtherLiabilitiesAndDeferredRevenueNoncurrent | Other Liabilities and Deferred Revenue, Noncurrent | USD | 80,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 392,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OtherLongTermDebtNoncurrent | Other Long-term Debt, Noncurrent | USD | 18,000 | 2022-12-31 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 458,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -116,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 62,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001213900-24-067897 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 4,971 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 2.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 23.60M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 249,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095173 | |
| us-gaap | OtherReceivables | Other Receivables | USD | 30.00M | 2026-07-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 663,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | OtherSellingGeneralAndAdministrativeExpense | Other Selling, General and Administrative Expense | USD | 1.70M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | OtherUnderwritingExpense | Other Underwriting Expense | USD | 3.50M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | PaymentsForFees | Payments for Other Fees | USD | 50.00M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 26,000 | 2022-07-01 | 2022-07-22 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock | Payments for Repurchase of Redeemable Convertible Preferred Stock | USD | 6.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | PaymentsForRepurchaseOfRedeemablePreferredStock | Payments for Repurchase of Redeemable Preferred Stock | USD | 600 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | PaymentsForRoyalties | Payments for Royalties | USD | 8.30M | 2024-12-01 | 2024-12-31 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | PaymentsForUnderwritingExpense | Payments for Underwriting Expense | USD | 2.00M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 235,896 | 2019-08-13 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 400,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 960,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | -7.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 100.00M | 2019-08-13 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 7,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | -77,310 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-13 | 0001213900-20-012038 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 7,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 21.72M | 2021-09-24 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | PreferredStockDividendsShares | Preferred Stock Dividends, Shares | shares | 10.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | PreferredStockLiquidationPreference | Preferred Stock, Liquidation Preference Per Share | USD/shares | 0.25 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 2.659 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 93,409 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-24 | 0001213900-21-028790 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-24 | 0001213900-21-028790 | |
| us-gaap | PreferredUnitsAuthorized | Preferred Units, Authorized | shares | 4.51M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 2.82M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 205,986 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001213900-20-036217 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 325,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 27,000 | 2021-12-31 | 2022 | Q2 | 10-Q | 2022-08-12 | 0001213900-22-047382 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 9,620 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 100.00M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001213900-20-036217 |
| us-gaap | ProceedsFromHedgeFinancingActivities | Proceeds from Hedge, Financing Activities | USD | 95.27M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 3.30M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001213900-24-067897 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 6.45M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 10.75M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 4.00M | 2019-08-13 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 132.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 64,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 725,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 1.07M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | -183,876 | 2019-08-13 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001213900-20-007505 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 105,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ProceedsFromSaleOfTreasuryStock | Proceeds from Sale of Treasury Stock | USD | 150.00M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 329,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 5.00M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 |
| us-gaap | ProductionAndDistributionCosts | Production and Distribution Costs | USD | 1.70M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | ProfessionalAndContractServicesExpense | Professional and Contract Services Expense | USD | 100,000 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001213900-24-095173 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 200,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 30.30M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 57,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 43.84M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | RelatedPartyCosts | Related Party Costs | USD | 7,050 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 44,364 | 2019-08-13 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | RelatedPartyTransactionRate | Related Party Transaction, Rate | pure | 0.05 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 183,876 | 2019-08-13 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 |
| us-gaap | ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount | Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount | pure | 1 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 19.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 2.30M | 2020-11-01 | 2020-11-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost | Research and Development Expense, Software (Excluding Acquired in Process Cost) | USD | 9.00M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 1.42M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 417,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 116.23M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 417,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 417,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | RestrictedStockExpense | Restricted Stock or Unit Expense | USD | 31.00M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | -960,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 2.30M | 2020-11-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.5 | 2025-07-01 | 2025-07-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 2.30M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | RestructuringSettlementAndImpairmentProvisions | Restructuring, Settlement and Impairment Provisions | USD | 25.53M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001213900-25-075635 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -465.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 9.00M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 |
| us-gaap | Revenues | Revenues | USD | 8.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.09M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 10.00M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 69.00M | 2023-01-31 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | SalesTypeLeaseRevenue | Sales-type Lease, Revenue | USD | 8.30M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 2.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 2.66M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.1 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate | Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | pure | 0.008 | 2020-07-27 | 2021-02-26 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 94,972 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001213900-22-025945 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value | USD/shares | 541,225 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 1.10M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0001213900-23-039021 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share | USD/shares | 35 | 2024-06-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 6.60M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 400,000 | 2024-06-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | USD/shares | 23.95 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.33 | 2024-06-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.049 | 2024-06-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures | shares | 262,619 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 468,115 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0001213900-24-042805 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 721,955 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001213900-25-107884 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 202,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 313,959 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 0.78 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 500,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 16,650 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 50,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.54 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001213900-22-025945 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 94,972 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001213900-22-025945 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 6.30M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-12 | 0001213900-22-047382 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 27 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 400,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 417,231 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 1.45 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 202,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 9.40M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 202,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 497,309 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 1.45 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 900,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056595 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 1.33 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056595 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 0.1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 65,001 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0.71 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 1.92 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.92 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 2.72M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate | pure | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | SharePrice | Share Price | USD/shares | 7.9 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 10 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.003 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 169,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 1,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | StockDividendsShares | Stock Dividends, Shares | shares | 4.52M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensationGross | Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture | USD | 2.49M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001213900-22-071165 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -140.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 101.79M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-13 | 0001213900-20-012038 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 4.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 900,000 | 2023-01-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 | |
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 4.66M | 2026-07-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | StockIssuedDuringPeriodSharesPurchaseOfAssets | Stock Issued During Period, Shares, Purchase of Assets | shares | 499,986 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001213900-25-075635 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 1.08M | 2023-10-01 | 2023-10-31 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationForfeited | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | shares | 200,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 4.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 94.06M | 2019-08-13 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001213900-20-007505 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.87M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 150.00M | 2022-10-01 | 2022-10-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 1,000 | 2023-07-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001213900-23-084970 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 329,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | -3.57M | 2021-04-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 |
| us-gaap | TaxCreditCarryforwardValuationAllowance | Tax Credit Carryforward, Valuation Allowance | USD | 77.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 16,225 | 2019-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 81.29M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001213900-21-043115 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 41.16M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | TemporaryEquityRedemptionPricePerShare | Temporary Equity, Redemption Price Per Share | USD/shares | 18 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-05-24 | 0001213900-21-028779 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 19.52M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 15.48M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 15.48M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 | |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 1.50M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0001213900-24-020114 | |
| us-gaap | UnamortizedDiscountsOnAcceptancesExecuted | Unamortized Discounts on Acceptances Executed | USD | 500,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 3.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 709,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 90,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | UnrecordedUnconditionalPurchaseObligationImputedInterest | Unrecorded Unconditional Purchase Obligation, Imputed Interest | USD | 412,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 16.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 535,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 3.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 | |
| us-gaap | WeightedAverageBasicSharesOutstandingProForma | Weighted Average Basic Shares Outstanding, Pro Forma | shares | 99.78M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0001213900-23-066234 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 28.68M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-089592 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted | Weighted Average Number of Limited Partnership and General Partnership Unit Outstanding, Basic and Diluted | shares | 36.48M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0001213900-23-018542 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 11.39M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-18 | 0001213900-22-013592 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 76,598 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001213900-26-036426 |
| us-gaap | WeightedAverageNumberOfSharesContingentlyIssuable | Weighted Average Number of Shares, Contingently Issuable | shares | 22,500 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001213900-26-120161 |
| us-gaap | WeightedAverageNumberOfSharesRestrictedStock | Weighted Average Number of Shares, Restricted Stock | shares | 7,256 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0001213900-25-018384 |